Kenneth D. Noonan, Ph.D., CEO Lightstone Singapore PTE. LTD.
Ken is currently the CEO of Lightstone Singapore Pte, Ltd.
Previously Ken was a consultant to the life science industry. Most recently he was a senior partner and head of the European Life Sciences Practice at L.E.K. Consulting LLP. Prior to that he was a partner in the pharmaceutical practice at Booz-Allen & Hamiliton. Ken was also the founding partner and head of the European practice at The Wilkerson Group Ltd. Ken’s operating experience in discovery includes management roles at Cooper Life Sciences (to include Technicon), Becton Dickinson and Bethesda Research Labs.
Ken has served as a Board member of both public and private life science companies in Europe and the U.S. to include Intercept Pharmaceuticals Inc., Kailos Genetics and Orchid Biosciences.
During his academic career Ken authored more than 50 articles on the role of the cell surface in cell division.
B.S. in Biology from St. Joseph’s University
Ph.D. in Biochemistry from Princeton University
See other team members.